Abstract

Background

Despite improved surgical approaches for chronic limb‐threatening ischemia (CLTI), amputation rates remain high and contributing tissue‐level factors remain unknown. The purpose of this study was twofold: (1) to identify differences between the healthy adult and CLTI limb muscle proteome, and (2) to identify differences in the limb muscle proteome of CLTI patients prior to surgical intervention or at the time of amputation.

Methods and results

Gastrocnemius muscle was collected from non‐ischemic controls (n = 19) and either pre‐interventional surgery (n = 10) or at amputation outcome (n = 29) CLTI patients. All samples were subjected to isobaric tandem‐mass‐tag‐assisted proteomics. The mitochondrion was the primary classification of downregulated proteins (> 70%) in CLTI limb muscles and paralleled robust functional mitochondrial impairment. Upregulated proteins (> 38%) were largely from the extracellular matrix. Across the two independent sites, 39 proteins were downregulated and 12 upregulated uniformly. Pre‐interventional CLTI muscles revealed a robust upregulation of mitochondrial proteins but modest functional impairments in fatty acid oxidation as compared with controls. Comparison of pre‐intervention and amputation CLTI limb muscles revealed mitochondrial proteome and functional deficits similar to that between amputation and non‐ischemic controls. Interestingly, these observed changes occurred despite 62% of the amputation CLTI patients having undergone a prior surgical intervention.

Conclusions

The CLTI proteome supports failing mitochondria as a phenotype that is unique to amputation outcomes. The signature of pre‐intervention CLTI muscle reveals stable mitochondrial protein abundance that is insufficient to uniformly prevent functional impairments. Taken together, these findings support the need for future longitudinal investigations aimed to determine whether mitochondrial failure is causally involved in amputation outcomes from CLTI.

Details

Title
Interventional‐ and amputation‐stage muscle proteomes in the chronically threatened ischemic limb
Author
Ryan, Terence E. 1   VIAFID ORCID Logo  ; Kim, Kyoungrae 2 ; Scali, Salvatore T. 3 ; Berceli, Scott A. 3 ; Thome, Trace 2 ; Salyers, Zachary R. 2 ; O'Malley, Kerri A. 3 ; Green, Thomas D. 4 ; Karnekar, Reema 4 ; Fisher‐Wellman, Kelsey H. 4 ; Yamaguchi, Dean J. 5 ; McClung, Joseph M. 6 

 Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA, Center for Exercise Science, University of Florida, Gainesville, Florida, USA, Myology Institute, University of Florida, Gainesville, Florida, USA 
 Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA 
 Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida, USA, Malcom Randall Veteran Affairs Medical Center, Gainesville, Florida, USA 
 Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA, East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, North Carolina, USA 
 Department of Cardiovascular Science, East Carolina University, Greenville, North Carolina, USA, Division of Surgery, East Carolina University, Greenville, North Carolina, USA 
 Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA, East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, North Carolina, USA, Department of Cardiovascular Science, East Carolina University, Greenville, North Carolina, USA 
Section
RESEARCH ARTICLES
Publication year
2022
Publication date
Jan 1, 2022
Publisher
John Wiley & Sons, Inc.
e-ISSN
20011326
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2760822659
Copyright
© 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.